OPTIMARK Side Effects

6637101-3 | Activities Of Daily Living Impaired, Anaphylactic Shock, Anxiety, Cardiac Failure Congestive, Clavicle Fracture, Conjunctivitis, Constipation, Depression
on Mar 04, 2010 Male patient from UNITED STATES , weighting 174.0 lb, was diagnosed with nuclear magnetic resonance imaging and was treated with Optimark (View Usage). Patient experienced the following unwanted or unexpected effects: activities of daily living impaired, anaphylactic shock, anxiety (What is anxiety?), cardiac failure congestive, clavicle fracture, conjunctivitis, constipation (What is constipation?), depression (What is depression?). Optimark dosage: 20 Ml, Single. During the same period patient was treated with MAGNEVIST (15 Ml, Single) (View Magnevist Review and Magnevist Label ), ALPRAZOLAM (0.5 Mg,1 Tablet Hs Prn) (View Alprazolam Review and Alprazolam Label ), ZITHROMAX (500 Mg, Tri-pak) (View Zithromax Review and Zithromax Label ). Patient was hospitalized.

6637100-1 | Feeling Cold, Injection Site Pain, Metastases To Bone, Metastases To Lymph Nodes, Oedema Peripheral, Off Label Use, Prostate Cancer Recurrent, Renal Cancer, Renal Impairment
Patient was taking Optimark (View Usage). Patient had the following side effects: feeling cold, injection site pain, metastases to bone, metastases to lymph nodes, oedema peripheral, off label use, prostate cancer recurrent, renal cancer, renal impairment on Mar 04, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 166.0 lb, was diagnosed with arthrogram, blood pressure (What is blood pressure?) and. Optimark dosage: Combined W/ Optiray To Make 14 Ml, Single. During the same period patient was treated with OPTIRAY 350 (Combined W/ Optimark To Make 14 Ml, Single) (View Optiray 350 Review and Optiray 350 Label ), XYLOCAINE (8 Ml (cc), Unk) (View Xylocaine Review and Xylocaine Label ). Patient was hospitalized.

6635295-7 | Abasia, Acute Coronary Syndrome, Acute Myocardial Infarction, Alopecia, Anaemia, Arteriovenous Fistula Site Complication, Atrial Fibrillation, Basal Cell Carcinoma, Cardiac Failure Congestive
Adverse event was reported on Mar 05, 2010 by a Female patient taking Optimark (View Usage) (Dosage: Unk) was diagnosed with nuclear magnetic resonance imaging, nuclear magnetic resonance imaging brain and. Location: UNITED STATES , weighting 183.0 lb, After Optimark was administered, patient had the following side effects: abasia, acute coronary syndrome, acute myocardial infarction, alopecia, anaemia, arteriovenous fistula site complication, atrial fibrillation (What is atrial fibrillation?), basal cell carcinoma, cardiac failure congestive. During the same period patient was treated with MAGNEVIST (Unk, Single) (View Magnevist Review and Magnevist Label ). Patient was hospitalized and became disabled.

6633339-X | Arterial Occlusive Disease, Chest Pain, Convulsion, Deep Vein Thrombosis, Encephalomalacia, Erosive Duodenitis, Fluid Overload, Haemorrhagic Stroke, Helicobacter Gastritis
on Feb 26, 2010 Female patient from UNITED STATES , weighting 165.0 lb, was diagnosed with nuclear magnetic resonance imaging brain, angiogram, arteriogram renal, vaginal infection, anxiety (What is anxiety?), hypertension, blood phosphorus increased and was treated with Optimark (View Usage). Patient experienced the following unwanted or unexpected effects: arterial occlusive disease, chest pain (What is chest pain?), convulsion, deep vein thrombosis (What is deep vein thrombosis?), encephalomalacia, erosive duodenitis, fluid overload, haemorrhagic stroke, helicobacter gastritis. Optimark dosage: 1 Ml, Single. During the same period patient was treated with MAGNEVIST (Unk) (View Magnevist Review and Magnevist Label ), GADOLINIUM (Unk) (View Gadolinium Review and Gadolinium Label ), DIFLUCAN (150 Mg, Qd) (View Diflucan Review and Diflucan Label ), XANAX (.25 Mg, Q12 Prn) (View Xanax Review and Xanax Label ), ATENOLOL (50 Mg, Bid) (View Atenolol Review and Atenolol Label ), RENAGEL /01459901/ (1600 Mg, Tid) (View Renagel /01459901/ Review and Renagel /01459901/ Label ).


6626201-X | Activities Of Daily Living Impaired, Anxiety, Cardiac Failure Congestive, Clavicle Fracture, Conjunctivitis, Constipation, Depression, Fall, Fungal Infection
on Mar 04, 2010 Male patient from UNITED STATES , weighting 174.0 lb, was diagnosed with nuclear magnetic resonance imaging and was treated with Optimark (View Usage). Patient had the following side effects: activities of daily living impaired, anxiety (What is anxiety?), cardiac failure congestive, clavicle fracture, conjunctivitis, constipation (What is constipation?), depression (What is depression?), fall (What is fall?), fungal infection (What is fungal infection?). Optimark dosage: Unk, Single. During the same period patient was treated with MAGNEVIST (15 Ml, Single) (View Magnevist Review and Magnevist Label ), GADOLINIUM (20 Ml, Single) (View Gadolinium Review and Gadolinium Label ). Patient was hospitalized.

6626012-5 | Activities Of Daily Living Impaired, Anxiety, Cardiac Failure Congestive, Clavicle Fracture, Conjunctivitis, Constipation, Depression, Fall, Fungal Infection
Patient was taking Optimark (View Usage). After Optimark was administered, patient had the following side effects: activities of daily living impaired, anxiety (What is anxiety?), cardiac failure congestive, clavicle fracture, conjunctivitis, constipation (What is constipation?), depression (What is depression?), fall (What is fall?), fungal infection (What is fungal infection?) on Mar 04, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 174.0 lb, was diagnosed with nuclear magnetic resonance imaging and. Optimark dosage: Unk, Single. During the same period patient was treated with MAGNEVIST (15 Ml, Single) (View Magnevist Review and Magnevist Label ), GADOLINIUM (20 Ml, Single) (View Gadolinium Review and Gadolinium Label ). Patient was hospitalized.

6621497-2 | Activities Of Daily Living Impaired, Cardiac Failure Congestive, Cholelithiasis, Cough, Dysarthria, Dyslipidaemia, Headache, Hepatic Cirrhosis, Hypothyroidism
Adverse event was reported on Feb 26, 2010 by a Male patient taking Optimark (View Usage) (Dosage: 20 Ml, Single) was diagnosed with nuclear magnetic resonance imaging brain and. Location: UNITED STATES , weighting 261.4 lb, Patient experienced the following unwanted or unexpected effects: activities of daily living impaired, cardiac failure congestive, cholelithiasis, cough, dysarthria, dyslipidaemia, headache (What is headache?), hepatic cirrhosis, hypothyroidism. During the same period patient was treated with GADOLINIUM (Unk, Single) (View Gadolinium Review and Gadolinium Label ), OMNISCAN (20 Ml, Single) (View Omniscan Review and Omniscan Label ), MAGNEVIST (20 Ml, Single) (View Magnevist Review and Magnevist Label ), LOTENSIN HCT (Unk) (View Lotensin Hct Review and Lotensin Hct Label ), CODEINE SULFATE (View Codeine Sulfate Review and Codeine Sulfate Label ).

6571588-X | Asthenia, Calciphylaxis, Encephalopathy, Intervertebral Disc Disorder, Lower Limb Fracture, Nephrogenic Systemic Fibrosis, Pericardial Effusion
on Jan 26, 2010 Male patient from GERMANY , weighting 223.0 lb, was diagnosed with nuclear magnetic resonance imaging brain, arteriogram carotid and was treated with Optimark (View Usage). Patient had the following side effects: asthenia, calciphylaxis, encephalopathy, intervertebral disc disorder, lower limb fracture, nephrogenic systemic fibrosis, pericardial effusion. Optimark dosage: 20 Ml, Single. During the same period patient was treated with MAGNEVIST (Unk, Unk, Single) (View Magnevist Review and Magnevist Label ), OMNISCAN (42 Ml, Single) (View Omniscan Review and Omniscan Label ), GADOLINIUM (Unk Unk, Single) (View Gadolinium Review and Gadolinium Label ), RENAGEL /01459901/ (Unk) (View Renagel /01459901/ Review and Renagel /01459901/ Label ), CELEBREX (Unk) (View Celebrex Review and Celebrex Label ), NIFEREX /01214501/ (Unk) (View Niferex /01214501/ Review and Niferex /01214501/ Label ).

6571583-0 | Ascites, Atrioventricular Block, Cardiac Failure, Cardiomyopathy, Cellulitis, Erythema, Facial Bones Fracture, Gouty Arthritis, Haemorrhage
on Jan 27, 2010 Male patient from UNITED STATES , weighting 195.0 lb, was diagnosed with nuclear magnetic resonance imaging, pain (What is pain?) and was treated with Optimark (View Usage). After Optimark was administered, patient had the following side effects: ascites, atrioventricular block, cardiac failure, cardiomyopathy (What is cardiomyopathy?), cellulitis (What is cellulitis?), erythema, facial bones fracture, gouty arthritis, haemorrhage. Optimark dosage: 18 Ml, Single. During the same period patient was treated with OMNISCAN (Unk,unk, Single) (View Omniscan Review and Omniscan Label ), ALLOPURINOL (300 Mg, Qd) (View Allopurinol Review and Allopurinol Label ), SYNTHROID (125 Ug, Qd) (View Synthroid Review and Synthroid Label ), LYRICA (75 Mg, Bid) (View Lyrica Review and Lyrica Label ), LORTAB (7.5 Mg, Bid, Prn) (View Lortab Review and Lortab Label ), ZAROXOLYN (2.5 Mg, Every Other Day) (View Zaroxolyn Review and Zaroxolyn Label ), COREG (25 Mg, Bid) (View Coreg Review and Coreg Label ).

6566173-X | Abnormal Behaviour, Allergic Granulomatous Angiitis, Anaemia, Anogenital Warts, Candidiasis, Cardiac Murmur, Clostridium Difficile Colitis, Confusional State
Patient was taking Optimark (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, allergic granulomatous angiitis, anaemia, anogenital warts, candidiasis, cardiac murmur, clostridium difficile colitis, confusional state on Jan 22, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 159.2 lb, was diagnosed with nuclear magnetic resonance imaging brain, angiogram, venogram renal and. Optimark dosage: 19 Ml, Single. During the same period patient was treated with OMNISCAN (Unk) (View Omniscan Review and Omniscan Label ). Patient was hospitalized.

6549830-0 | Activities Of Daily Living Impaired, Anxiety, Cardiac Failure Congestive, Clavicle Fracture, Conjunctivitis, Constipation, Depression, Fall, Fungal Infection
Adverse event was reported on Jan 15, 2010 by a Male patient taking Optimark (View Usage) (Dosage: 15 Ml, Single) was diagnosed with nuclear magnetic resonance imaging and. Location: UNITED STATES , weighting 174.0 lb, Patient had the following side effects: activities of daily living impaired, anxiety (What is anxiety?), cardiac failure congestive, clavicle fracture, conjunctivitis, constipation (What is constipation?), depression (What is depression?), fall (What is fall?), fungal infection (What is fungal infection?). During the same period patient was treated with MAGNEVIST (15 Ml, Single) (View Magnevist Review and Magnevist Label ), GADOLINIUM (20 Ml, Single) (View Gadolinium Review and Gadolinium Label ), ALPRAZOLAM (0.5 Mg,1 Tablet Hs Prn) (View Alprazolam Review and Alprazolam Label ). Patient was hospitalized.

6527647-0 | Chest Pain, Dyspnoea, Headache, Heart Rate Increased, Off Label Use
on Oct 30, 2009 Female patient from UNITED STATES , weighting 140.0 lb, was diagnosed with nuclear magnetic resonance imaging, contraception and was treated with Optimark (View Usage). After Optimark was administered, patient had the following side effects: chest pain (What is chest pain?), dyspnoea, headache (What is headache?), heart rate increased, off label use. Optimark dosage: 20 Ml, Single. During the same period patient was treated with YAZ (Unk) (View Yaz Review and Yaz Label ).

6527310-6 | Nuclear Magnetic Resonance Imaging Abnormal, Off Label Use
on Mar 05, 2009 Female patient from UNITED STATES , weighting 120.0 lb, was diagnosed with arthrogram and was treated with Optimark (View Usage). Patient experienced the following unwanted or unexpected effects: nuclear magnetic resonance imaging abnormal, off label use. Optimark dosage: Unk.

6527307-6 | Abdominal Pain, Hypoaesthesia, Paraesthesia, Paraesthesia Oral
Patient was taking Optimark (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), hypoaesthesia, paraesthesia, paraesthesia oral on Aug 24, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 170.0 lb, was diagnosed with nuclear magnetic resonance imaging brain and. Optimark dosage: 10 Ml, Single.

6527306-4 | Injection Site Coldness, Injection Site Extravasation
Adverse event was reported on Jun 19, 2009 by a Female patient taking Optimark (View Usage) (Dosage: 20 Ml, Single) was diagnosed with nuclear magnetic resonance imaging and. Location: UNITED STATES , 58 years of age, After Optimark was administered, patient had the following side effects: injection site coldness, injection site extravasation.

6527302-7 | Abdominal Distension, Abdominal Pain, Arrhythmia, Chest Pain, Dizziness, Fatigue, Headache, Injection Site Extravasation
on Jan 14, 2009 Female patient from UNITED STATES , 40 years of age, weighting 150.0 lb, was diagnosed with nuclear magnetic resonance imaging, thyroid disorder, iron deficiency anaemia and was treated with Optimark (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, abdominal pain (What is abdominal pain?), arrhythmia (What is arrhythmia?), chest pain (What is chest pain?), dizziness (What is dizziness?), fatigue, headache (What is headache?), injection site extravasation. Optimark dosage: Unk. During the same period patient was treated with IRON (Unk) (View Iron Review and Iron Label ).

6527300-3 | Injection Site Extravasation, Injection Site Haemorrhage, Injection Site Pain, Injection Site Swelling
on Apr 08, 2009 Female patient from UNITED STATES , weighting 115.0 lb, was diagnosed with angiogram and was treated with Optimark (View Usage). Patient had the following side effects: injection site extravasation, injection site haemorrhage, injection site pain, injection site swelling. Optimark dosage: 30 Ml (cc), Single (rate Of 2 Cc/sec). During the same period patient was treated with SODIUM CHLORIDE (50 Ml (cc), Single (rate Of 2 Cc/sec)) (View Sodium Chloride Review and Sodium Chloride Label ).

6527299-X | Injection Site Extravasation
Patient was taking Optimark (View Usage). After Optimark was administered, patient had the following side effects: injection site extravasation on Jun 04, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 198.0 lb, was diagnosed with nuclear magnetic resonance imaging and. Optimark dosage: 20 Ml, Single.

6527298-8 | Micturition Urgency
Adverse event was reported on Jan 08, 2009 by a Female patient taking Optimark (View Usage) (Dosage: 20 Ml, Single) was diagnosed with nuclear magnetic resonance imaging and. Location: UNITED STATES , 38 years of age, weighting 142.0 lb, Patient experienced the following unwanted or unexpected effects: micturition urgency.

6527297-6 | Injection Site Extravasation
on Jun 04, 2009 Male patient from UNITED STATES , weighting 259.9 lb, was diagnosed with nuclear magnetic resonance imaging and was treated with Optimark (View Usage). Patient had the following side effects: injection site extravasation. Optimark dosage: 20 Ml, Single.

6527296-4 | Oral Pruritus, Throat Irritation
on Feb 03, 2009 Male patient from UNITED STATES , weighting 180.0 lb, was diagnosed with nuclear magnetic resonance imaging and was treated with Optimark (View Usage). After Optimark was administered, patient had the following side effects: oral pruritus, throat irritation. Optimark dosage: 16 Ml, Single.

6527292-7 | Injection Site Extravasation
Patient was taking Optimark (View Usage). Patient experienced the following unwanted or unexpected effects: injection site extravasation on Aug 03, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 170.0 lb, . Optimark dosage: 15 Ml, Single.

6527282-4 | Skin Discolouration
Adverse event was reported on Dec 10, 2008 by a Male patient taking Optimark (View Usage) (Dosage: 16 Ml, Single) was diagnosed with nuclear magnetic resonance imaging and. Location: UNITED STATES , 54 years of age, weighting 170.0 lb, Patient had the following side effects: skin discolouration.

6525617-X | Chest Pain, Dyspnoea, Headache, Heart Rate Increased, Off Label Use
on Oct 30, 2009 Female patient from UNITED STATES , weighting 140.0 lb, was diagnosed with nuclear magnetic resonance imaging, contraception and was treated with Optimark (View Usage). After Optimark was administered, patient had the following side effects: chest pain (What is chest pain?), dyspnoea, headache (What is headache?), heart rate increased, off label use. Optimark dosage: 20 Ml, Single. During the same period patient was treated with YAZ (Unk) (View Yaz Review and Yaz Label ).

6503145-5 | Angina Unstable, Anhedonia, Aortic Valve Incompetence, Aortic Valve Sclerosis, Aortic Valve Stenosis, Cardiac Failure Congestive, Diverticulum, Fall, Haemodialysis
on Dec 02, 2009 Female patient from UNITED STATES , weighting 135.0 lb, was diagnosed with angiogram and was treated with Optimark (View Usage). Patient experienced the following unwanted or unexpected effects: angina unstable, anhedonia, aortic valve incompetence, aortic valve sclerosis, aortic valve stenosis, cardiac failure congestive, diverticulum, fall (What is fall?), haemodialysis. Optimark dosage: Unk. During the same period patient was treated with MAGNEVIST (Unk) (View Magnevist Review and Magnevist Label ), VERAPAMIL (240 Mg, Qd) (View Verapamil Review and Verapamil Label ), HYDROXYUREA (500 Mg, Bid) (View Hydroxyurea Review and Hydroxyurea Label ). Patient was hospitalized.

6467659-9 | Abdominal Pain Upper, Arteriovenous Graft Site Infection, Atrial Fibrillation, Atrioventricular Block First Degree, Blood Glucose Fluctuation, Carcinoid Tumour, Cellulitis, Depressed Level Of Consciousness, Device Related Infection
Patient was taking Optimark (View Usage). Patient had the following side effects: abdominal pain upper, arteriovenous graft site infection, atrial fibrillation (What is atrial fibrillation?), atrioventricular block first degree, blood glucose fluctuation, carcinoid tumour, cellulitis (What is cellulitis?), depressed level of consciousness, device related infection on Nov 25, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 186.0 lb, was diagnosed with nuclear magnetic resonance imaging abdominal, nuclear magnetic resonance imaging brain and. Optimark dosage: 15 Ml, Single. During the same period patient was treated with MAGNEVIST (20 Ml, Single) (View Magnevist Review and Magnevist Label ), LANTUS (28 Units In Am) (View Lantus Review and Lantus Label ), PHOSLO (2 G, Tid) (View Phoslo Review and Phoslo Label ), REGLAN (5 Mg Ac) (View Reglan Review and Reglan Label ), ACIPHEX (20 Mg, Qd) (View Aciphex Review and Aciphex Label ). Patient was hospitalized.

6440473-6 | Asthma, Headache, Nausea, Pruritus
Adverse event was reported on Nov 03, 2009 by a Female patient taking Optimark (View Usage) (Dosage: 15 Ml, Single) was diagnosed with nuclear magnetic resonance imaging brain and. Location: UNITED STATES , weighting 140.0 lb, After Optimark was administered, patient had the following side effects: asthma (What is asthma?), headache (What is headache?), nausea (What is nausea?), pruritus.

6433136-4 | Chest Pain, Dyspnoea, Headache, Heart Rate Increased, Off Label Use
on Oct 30, 2009 Female patient from UNITED STATES , weighting 140.0 lb, was diagnosed with nuclear magnetic resonance imaging, contraception and was treated with Optimark (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), dyspnoea, headache (What is headache?), heart rate increased, off label use. Optimark dosage: 20 Ml, Single. During the same period patient was treated with YAZ (Unk) (View Yaz Review and Yaz Label ).

6424774-3 | Nephrogenic Systemic Fibrosis, Off Label Use
on Oct 23, 2009 Female patient from UNITED STATES , 60 years of age, was diagnosed with nuclear magnetic resonance imaging and was treated with Optimark (View Usage). Patient had the following side effects: nephrogenic systemic fibrosis, off label use. Optimark dosage: 30 Ml, Single.

6416149-8 | Abdominal Distension, Ammonia Increased, Asthenia, Auricular Perichondritis, Blood Glucose Increased, Confusional State, Diarrhoea Haemorrhagic, Diverticulum, Fatigue
Patient was taking Optimark (View Usage). After Optimark was administered, patient had the following side effects: abdominal distension, ammonia increased, asthenia, auricular perichondritis, blood glucose increased, confusional state, diarrhoea haemorrhagic, diverticulum, fatigue on Oct 14, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 156.0 lb, was diagnosed with nuclear magnetic resonance imaging and. Optimark dosage: . During the same period patient was treated with MAGNEVIST (View Magnevist Review and Magnevist Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), RENAGEL /01459901/ (View Renagel /01459901/ Review and Renagel /01459901/ Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLARITIN /00917501/ (View Claritin /00917501/ Review and Claritin /00917501/ Label ).

6412911-6 | Chest Pain, Dyspnoea, Headache, Heart Rate Increased, Off Label Use
Adverse event was reported on Oct 14, 2009 by a Female patient taking Optimark (View Usage) (Dosage: 20 Ml, Single) was diagnosed with nuclear magnetic resonance imaging, contraception and. Location: UNITED STATES , weighting 140.0 lb, Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), dyspnoea, headache (What is headache?), heart rate increased, off label use. During the same period patient was treated with YAZ (Unk) (View Yaz Review and Yaz Label ).

6409886-2 | Arrhythmia, Nephrogenic Systemic Fibrosis
on Oct 12, 2009 Female patient from UNITED STATES , weighting 116.2 lb, was diagnosed with nuclear magnetic resonance imaging brain, blood pressure (What is blood pressure?), dialysis (What is dialysis?), pain (What is pain?) and was treated with Optimark (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?), nephrogenic systemic fibrosis. Optimark dosage: 15 Ml (cc), Single. During the same period patient was treated with COZAAR (Unk) (View Cozaar Review and Cozaar Label ), SENSIPAR (90 Mg, Unk) (View Sensipar Review and Sensipar Label ), RENAGEL /01459901/ (800 Mg, Unk) (View Renagel /01459901/ Review and Renagel /01459901/ Label ), OXYCONTIN (Unk) (View Oxycontin Review and Oxycontin Label ), PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ), IRON (View Iron Review and Iron Label ), VITAMINS /90003601/ (View Vitamins /90003601/ Review and Vitamins /90003601/ Label ).

6403170-9 | Arrhythmia, Nephrogenic Systemic Fibrosis
on Oct 07, 2009 Female patient from UNITED STATES , weighting 110.2 lb, was diagnosed with nuclear magnetic resonance imaging brain, blood pressure (What is blood pressure?), dialysis (What is dialysis?), pain (What is pain?) and was treated with Optimark (View Usage). After Optimark was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), nephrogenic systemic fibrosis. Optimark dosage: 15 Ml (cc), Single (optimark Or Magnevist). During the same period patient was treated with MAGNEVIST (Unk) (View Magnevist Review and Magnevist Label ), COZAAR (Unk) (View Cozaar Review and Cozaar Label ), SENSIPAR (90 Mg, Unk) (View Sensipar Review and Sensipar Label ), RENAGEL /01459901/ (800 Mg, Unk) (View Renagel /01459901/ Review and Renagel /01459901/ Label ), OXYCONTIN (Unk) (View Oxycontin Review and Oxycontin Label ), PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ), IRON (View Iron Review and Iron Label ), VITAMINS /90003601/ (View Vitamins /90003601/ Review and Vitamins /90003601/ Label ).

6396445-3 | Atrioventricular Block Second Degree, Cardiac Failure Congestive, Carotid Artery Stenosis, Coronary Artery Disease, Nephrogenic Systemic Fibrosis, Neuropathy Peripheral, Off Label Use, Osteoarthritis, Pulmonary Hypertension
Patient was taking Optimark (View Usage). Patient experienced the following unwanted or unexpected effects: atrioventricular block second degree, cardiac failure congestive, carotid artery stenosis, coronary artery disease (What is coronary artery disease?), nephrogenic systemic fibrosis, neuropathy peripheral, off label use, osteoarthritis (What is osteoarthritis?), pulmonary hypertension (What is pulmonary hypertension?) on Oct 01, 2009 from UNITED STATES Additional patient health information: Male patient , 68 years of age, was diagnosed with nuclear magnetic resonance imaging, angiogram and. Optimark dosage: Unk. During the same period patient was treated with MAGNEVIST (Unk) (View Magnevist Review and Magnevist Label ), OMNISCAN (Unk) (View Omniscan Review and Omniscan Label ), MULTIHANCE (Unk) (View Multihance Review and Multihance Label ), PROHANCE (Unk) (View Prohance Review and Prohance Label ), GADOLINIUM (Unk) (View Gadolinium Review and Gadolinium Label ). Patient was hospitalized.

6396221-1 | Anaemia, Arthritis, Coagulopathy, Fibromyalgia, Hyperthyroidism, Lacunar Infarction, Nephrogenic Systemic Fibrosis, Superior Vena Caval Occlusion
Adverse event was reported on Sep 30, 2009 by a Male patient taking Optimark (View Usage) (Dosage: Unk) was diagnosed with nuclear magnetic resonance imaging brain, mineral supplementation, impaired gastric emptying, arthralgia, musculoskeletal pain and. Location: UNITED STATES , weighting 234.8 lb, Patient had the following side effects: anaemia, arthritis (What is arthritis?), coagulopathy, fibromyalgia, hyperthyroidism, lacunar infarction, nephrogenic systemic fibrosis, superior vena caval occlusion. During the same period patient was treated with OMNISCAN (20 Ml, Single) (View Omniscan Review and Omniscan Label ), PHOSLO (16 Tabs Daily) (View Phoslo Review and Phoslo Label ), METOPROLOL (50 Mg (1 Tab), Qd) (View Metoprolol Review and Metoprolol Label ), REGLAN (5 Mg, A.c) (View Reglan Review and Reglan Label ), OXYCODONE (5 Mg, Q4h) (View Oxycodone Review and Oxycodone Label ), OXYCONTIN (1-2 Times Daily) (View Oxycontin Review and Oxycontin Label ).

6395732-2 | Atrial Fibrillation, Cardiac Arrest, Cardiac Murmur, Cellulitis, Clostridium Difficile Colitis, Conjunctivitis, Ear Disorder, Encephalopathy, Endocarditis Bacterial
on Sep 30, 2009 Female patient from UNITED STATES , weighting 140.0 lb, was diagnosed with angiogram, nuclear magnetic resonance imaging brain and was treated with Optimark (View Usage). After Optimark was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), cardiac arrest (What is cardiac arrest?), cardiac murmur, cellulitis (What is cellulitis?), clostridium difficile colitis, conjunctivitis, ear disorder, encephalopathy, endocarditis bacterial. Optimark dosage: Unk. During the same period patient was treated with MAGNEVIST (Unk) (View Magnevist Review and Magnevist Label ), NEXIUM (40 Mg, Qd) (View Nexium Review and Nexium Label ), KLONOPIN (0.5 Mg, Qd) (View Klonopin Review and Klonopin Label ), NEPHROCAPS (One Capsule Per Day) (View Nephrocaps Review and Nephrocaps Label ), RENAGEL /01459901/ (800 Mg, Tid (with Each Meal)) (View Renagel /01459901/ Review and Renagel /01459901/ Label ), LABETALOL HCL (300 Mg, Bid) (View Labetalol Hcl Review and Labetalol Hcl Label ), HYDRALAZINE HCL (50 Mg, Bid) (View Hydralazine Hcl Review and Hydralazine Hcl Label ). Patient was hospitalized.

6393946-9 | Ascites, Back Pain, Breast Mass, Bundle Branch Block Left, Cardiac Failure Congestive, Clubbing, Duodenitis, Eustachian Tube Dysfunction, Gastritis
on Sep 28, 2009 Female patient from UNITED STATES , weighting 138.0 lb, was diagnosed with angiogram, venogram, hypertension, dialysis (What is dialysis?) and was treated with Optimark (View Usage). Patient experienced the following unwanted or unexpected effects: ascites, back pain (What is back pain?), breast mass, bundle branch block left, cardiac failure congestive, clubbing, duodenitis, eustachian tube dysfunction, gastritis. Optimark dosage: Unk. During the same period patient was treated with HYDRALAZINE HCL (100 Mg (2 Tablets), Tid) (View Hydralazine Hcl Review and Hydralazine Hcl Label ), COZAAR (50 Mg, Qd) (View Cozaar Review and Cozaar Label ), IMDUR (30 Mg, Qd) (View Imdur Review and Imdur Label ), CLONIDINE (0.1 Mg, Bid) (View Clonidine Review and Clonidine Label ), PHOSLO (667 Mg, Tid (1 Tablet With Meals)) (View Phoslo Review and Phoslo Label ), RENAGEL /01459901/ (1600 Mg, Tid) (View Renagel /01459901/ Review and Renagel /01459901/ Label ), PREVACID (30 Mg, Qd (1 Tablet Before Breakfast)) (View Prevacid Review and Prevacid Label ). Patient was hospitalized.

6339007-6 | Anxiety, Cardiac Failure Congestive, Clavicle Fracture, Conjunctivitis, Constipation, Depression, Fall, Fungal Infection, Hypokalaemia
Patient was taking Optimark (View Usage). Patient had the following side effects: anxiety (What is anxiety?), cardiac failure congestive, clavicle fracture, conjunctivitis, constipation (What is constipation?), depression (What is depression?), fall (What is fall?), fungal infection (What is fungal infection?), hypokalaemia on Aug 24, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 174.0 lb, was diagnosed with nuclear magnetic resonance imaging and. Optimark dosage: 15 Ml, Single. During the same period patient was treated with MAGNEVIST (15 Ml, Single) (View Magnevist Review and Magnevist Label ), GADOLINIUM (20 Ml, Single) (View Gadolinium Review and Gadolinium Label ), ALPRAZOLAM (0.5 Mg,1 Tablet Hs Prn) (View Alprazolam Review and Alprazolam Label ), ZITHROMAX (500 Mg, Tri-pak) (View Zithromax Review and Zithromax Label ). Patient was hospitalized.

6338217-1 | Ascites, Nephrogenic Systemic Fibrosis, Renal Artery Stenosis
Adverse event was reported on Aug 21, 2009 by a Male patient taking Optimark (View Usage) (Dosage: 18 Ml, Single) was diagnosed with nuclear magnetic resonance imaging, pain (What is pain?) and. Location: UNITED STATES , weighting 195.0 lb, After Optimark was administered, patient had the following side effects: ascites, nephrogenic systemic fibrosis, renal artery stenosis. During the same period patient was treated with OMNISCAN (Unk) (View Omniscan Review and Omniscan Label ), ALLOPURINOL (300 Mg, Qd) (View Allopurinol Review and Allopurinol Label ), SYNTHROID (125 Ug, Qd) (View Synthroid Review and Synthroid Label ), LYRICA (75 Mg, Bid) (View Lyrica Review and Lyrica Label ), LORTAB (7.5 Mg, Bid, Prn) (View Lortab Review and Lortab Label ), ZAROXOLYN (2.5 Mg, Every Other Day) (View Zaroxolyn Review and Zaroxolyn Label ), COREG (25 Mg, Bid) (View Coreg Review and Coreg Label ).

6337761-0 | Abasia, Acute Coronary Syndrome, Alopecia, Arteriovenous Fistula Site Complication, Atrial Fibrillation, Basal Cell Carcinoma, Cardiac Failure Congestive, Carotid Artery Stenosis, Chest Pain
on Aug 21, 2009 Female patient from UNITED STATES , weighting 183.0 lb, was diagnosed with nuclear magnetic resonance imaging, nuclear magnetic resonance imaging brain and was treated with Optimark (View Usage). Patient experienced the following unwanted or unexpected effects: abasia, acute coronary syndrome, alopecia, arteriovenous fistula site complication, atrial fibrillation (What is atrial fibrillation?), basal cell carcinoma, cardiac failure congestive, carotid artery stenosis, chest pain (What is chest pain?). Optimark dosage: Unk, Single. During the same period patient was treated with MAGNEVIST (Unk, Single) (View Magnevist Review and Magnevist Label ).

6336612-8 | Bacteraemia, Decubitus Ulcer, Nephrogenic Systemic Fibrosis, Oedema Peripheral
on Aug 21, 2009 Female patient from UNITED STATES , weighting 178.6 lb, was diagnosed with nuclear magnetic resonance imaging brain and was treated with Optimark (View Usage). Patient had the following side effects: bacteraemia, decubitus ulcer, nephrogenic systemic fibrosis, oedema peripheral. Optimark dosage: Unk. During the same period patient was treated with GADOLINIUM (Unk) (View Gadolinium Review and Gadolinium Label ), OMNISCAN (Unk) (View Omniscan Review and Omniscan Label ), MAGNEVIST (Unk) (View Magnevist Review and Magnevist Label ), LONITEN (2.5 Mg, Qd (am)) (View Loniten Review and Loniten Label ), LIPITOR (20 Mg, Qd (night)) (View Lipitor Review and Lipitor Label ), COUMADIN (3 Mg, Qd) (View Coumadin Review and Coumadin Label ).

6336611-6 | Angina Unstable, Arteriovenous Fistula Site Complication, Arteriovenous Graft Thrombosis, Diarrhoea, Dysphagia, Electrocardiogram Qt Shortened, Electrocardiogram St Segment Depression, Electrocardiogram T Wave Abnormal, Hyperlipidaemia
Patient was taking Optimark (View Usage). After Optimark was administered, patient had the following side effects: angina unstable, arteriovenous fistula site complication, arteriovenous graft thrombosis, diarrhoea, dysphagia, electrocardiogram qt shortened, electrocardiogram st segment depression, electrocardiogram t wave abnormal, hyperlipidaemia on Aug 21, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 181.7 lb, was diagnosed with nuclear magnetic resonance imaging and. Optimark dosage: 20 Ml, Single. During the same period patient was treated with PROHANCE (17 Ml, Single) (View Prohance Review and Prohance Label ), INSULIN (3 Units, Qd (am)) (View Insulin Review and Insulin Label ), CATAPRES /00171101/ (0.3 Mg, Bid) (View Catapres /00171101/ Review and Catapres /00171101/ Label ), NORVASC (10 Mg, Qd) (View Norvasc Review and Norvasc Label ), ATACAND (32 Mg, Qd) (View Atacand Review and Atacand Label ), NEPHROCAPS (1 Tab, Qd) (View Nephrocaps Review and Nephrocaps Label ), RENAGEL /01459901/ (3200 Mg, With Each Meal) (View Renagel /01459901/ Review and Renagel /01459901/ Label ), SYNTHROID (25 Ug, Qd) (View Synthroid Review and Synthroid Label ). Patient was hospitalized.

6334906-3 | Atrioventricular Block Second Degree, Cardiac Failure Congestive, Carotid Artery Stenosis, Coronary Artery Disease, Nephrogenic Systemic Fibrosis, Neuropathy Peripheral, Off Label Use, Osteoarthritis, Pulmonary Hypertension
Adverse event was reported on Aug 18, 2009 by a Male patient taking Optimark (View Usage) (Dosage: Unk) was diagnosed with nuclear magnetic resonance imaging, angiogram and. Location: UNITED STATES , 68 years of age, Patient experienced the following unwanted or unexpected effects: atrioventricular block second degree, cardiac failure congestive, carotid artery stenosis, coronary artery disease (What is coronary artery disease?), nephrogenic systemic fibrosis, neuropathy peripheral, off label use, osteoarthritis (What is osteoarthritis?), pulmonary hypertension (What is pulmonary hypertension?). During the same period patient was treated with MAGNEVIST (Unk) (View Magnevist Review and Magnevist Label ), OMNISCAN (Unk) (View Omniscan Review and Omniscan Label ), MULTIHANCE (Unk) (View Multihance Review and Multihance Label ), PROHANCE (Unk) (View Prohance Review and Prohance Label ), GADOLINIUM (Unk) (View Gadolinium Review and Gadolinium Label ). Patient was hospitalized.

6334813-6 | Abnormal Behaviour, Allergic Granulomatous Angiitis, Anaemia, Anogenital Warts, Candidiasis, Cardiac Murmur, Clostridium Difficile Colitis, Confusional State
on Aug 18, 2009 Male patient from UNITED STATES , weighting 159.2 lb, was diagnosed with nuclear magnetic resonance imaging brain, angiogram, venogram renal and was treated with Optimark (View Usage). Patient had the following side effects: abnormal behaviour, allergic granulomatous angiitis, anaemia, anogenital warts, candidiasis, cardiac murmur, clostridium difficile colitis, confusional state. Optimark dosage: 19 Ml, Single. During the same period patient was treated with OMNISCAN (View Omniscan Review and Omniscan Label ). Patient was hospitalized.

6334705-2 | Abdominal Pain Upper, Arteriovenous Graft Site Infection, Atrial Fibrillation, Atrioventricular Block First Degree, Blood Glucose Fluctuation, Carcinoid Tumour, Catheter Related Infection, Cellulitis, Depressed Level Of Consciousness
on Aug 18, 2009 Male patient from UNITED STATES , weighting 186.0 lb, was diagnosed with nuclear magnetic resonance imaging abdominal, nuclear magnetic resonance imaging brain and was treated with Optimark (View Usage). After Optimark was administered, patient had the following side effects: abdominal pain upper, arteriovenous graft site infection, atrial fibrillation (What is atrial fibrillation?), atrioventricular block first degree, blood glucose fluctuation, carcinoid tumour, catheter related infection, cellulitis (What is cellulitis?), depressed level of consciousness. Optimark dosage: 15 Ml, Single. During the same period patient was treated with MAGNEVIST (20 Ml, Single) (View Magnevist Review and Magnevist Label ), LANTUS (28 Units In Am) (View Lantus Review and Lantus Label ), PHOSLO (2 G, Tid) (View Phoslo Review and Phoslo Label ), REGLAN (5 Mg Ac) (View Reglan Review and Reglan Label ), ACIPHEX (20 Mg, Qd) (View Aciphex Review and Aciphex Label ). Patient was hospitalized.

6317087-1 | Abdominal Hernia, Abdominal Wound Dehiscence, Amputation, Ascites, Atelectasis, Bone Lesion, Cardiac Failure Congestive, Cardiomegaly, Cerebral Atrophy
Patient was taking Optimark (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal hernia, abdominal wound dehiscence, amputation, ascites, atelectasis, bone lesion, cardiac failure congestive, cardiomegaly, cerebral atrophy on Aug 10, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 255.0 lb, was diagnosed with nuclear magnetic resonance imaging, angiogram and. Optimark dosage: Unk, Single.

6309446-8 | Aortic Valve Incompetence, Cardiac Failure Congestive, Diverticulum, Fall, Hip Fracture, Nephrogenic Systemic Fibrosis, Off Label Use, Renal Failure Chronic, Urinary Tract Infection
Adverse event was reported on Aug 04, 2009 by a Female patient taking Optimark (View Usage) (Dosage: Unk) was diagnosed with angiogram and. Location: UNITED STATES , weighting 135.0 lb, Patient had the following side effects: aortic valve incompetence, cardiac failure congestive, diverticulum, fall (What is fall?), hip fracture, nephrogenic systemic fibrosis, off label use, renal failure chronic, urinary tract infection (What is urinary tract infection?). During the same period patient was treated with MAGNEVIST (Unk) (View Magnevist Review and Magnevist Label ), VERAPAMIL (240 Mg, Qd) (View Verapamil Review and Verapamil Label ), HYDROXYUREA (500 Mg, Bid) (View Hydroxyurea Review and Hydroxyurea Label ). Patient was hospitalized.

6309445-6 | Abscess Limb, Atrial Fibrillation, Catheter Related Infection, Depression, Episcleritis, Nephrogenic Systemic Fibrosis
on Aug 03, 2009 Female patient from UNITED STATES , weighting 150.0 lb, was diagnosed with scan, nuclear magnetic resonance imaging, thrombosis, anaemia, vitamin supplementation and was treated with Optimark (View Usage). After Optimark was administered, patient had the following side effects: abscess limb, atrial fibrillation (What is atrial fibrillation?), catheter related infection, depression (What is depression?), episcleritis, nephrogenic systemic fibrosis. Optimark dosage: Unk, Single. During the same period patient was treated with OMNISCAN (30 (unit Not Provided)) (View Omniscan Review and Omniscan Label ), MAGNEVIST (View Magnevist Review and Magnevist Label ), MULTIHANCE (View Multihance Review and Multihance Label ), PROHANCE (View Prohance Review and Prohance Label ), COUMADIN (2.5 To 5 Mg/day) (View Coumadin Review and Coumadin Label ), EPOGEN (Unk) (View Epogen Review and Epogen Label ), VITAMINS NOS (Unk) (View Vitamins Nos Review and Vitamins Nos Label ), IRON (Unk) (View Iron Review and Iron Label ). Patient was hospitalized.

6299297-5 | Activities Of Daily Living Impaired, Chest Pain, Diaphragmatic Disorder, Dysphagia, Dyspnoea, Gastritis, Nephrogenic Systemic Fibrosis, Off Label Use, Pericarditis Constrictive
on Jul 29, 2009 Female patient from UNITED STATES , weighting 233.0 lb, was diagnosed with nuclear magnetic resonance imaging brain, angiogram and was treated with Optimark (View Usage). Patient experienced the following unwanted or unexpected effects: activities of daily living impaired, chest pain (What is chest pain?), diaphragmatic disorder, dysphagia, dyspnoea, gastritis, nephrogenic systemic fibrosis, off label use, pericarditis constrictive. Optimark dosage: Unk, Unk. During the same period patient was treated with MAGNEVIST (20 Ml, Single) (View Magnevist Review and Magnevist Label ), ASPIRIN (81 Mg, Qd) (View Aspirin Review and Aspirin Label ), RENAGEL /01459901/ (800 Mg, 5 Tabs/meal, 2 Tabs/snack) (View Renagel /01459901/ Review and Renagel /01459901/ Label ), SENSIPAR (60 Mg, Qd) (View Sensipar Review and Sensipar Label ), NEPHROVITE (1 Tab, Qd) (View Nephrovite Review and Nephrovite Label ), VICODIN (View Vicodin Review and Vicodin Label ).

6299296-3 | Abscess, Cardiac Failure Congestive, Depression, Joint Sprain, Myocardial Infarction, Nephrogenic Systemic Fibrosis, Off Label Use, Osteomyelitis, Pneumonia
Patient was taking Optimark (View Usage). Patient had the following side effects: abscess (What is abscess?), cardiac failure congestive, depression (What is depression?), joint sprain, myocardial infarction, nephrogenic systemic fibrosis, off label use, osteomyelitis, pneumonia (What is pneumonia?) on Jul 28, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 180.0 lb, was diagnosed with nuclear magnetic resonance imaging, angiogram and. Optimark dosage: 20 Ml (cc), Single. During the same period patient was treated with OMNISCAN (Unk) (View Omniscan Review and Omniscan Label ), MAGNEVIST (18 Ml, Single) (View Magnevist Review and Magnevist Label ), METOPROLOL SUCCINATE (50 Mg, Bid) (View Metoprolol Succinate Review and Metoprolol Succinate Label ), AMIODARONE HCL (200 Mg, Qd) (View Amiodarone Hcl Review and Amiodarone Hcl Label ), MS CONTIN (60 Mg, Bid) (View Ms Contin Review and Ms Contin Label ). Patient was hospitalized.